Navigation Links
FASEB Welcomes New President, William T. Talman, M.D.
Date:7/1/2010

BETHESDA, Md., July 1 /PRNewswire-USNewswire/ -- William T. Talman, M.D., assumed office as the 95th President of the Federation of American Societies for Experimental Biology (FASEB) on July 1, 2010. Talman is a Professor of Neurology and Neuroscience at the University of Iowa and is a practicing physician at the University Hospital and at the Iowa City Veterans Affairs (VA) hospital where he is the Chief of the Neurology Service. He will serve for one year as the leader of FASEB, a coalition of 23 member societies comprising more than 100,000 scientists and engineers.

"The opportunities for continued progress have never been greater, but those opportunities depend on adequate resources," Talman stated. "In 2009, supplemental appropriations from the American Recovery and Reinvestment Act (ARRA) restored purchasing power at the National Institutes of Health (NIH) and provided a timely investment in biomedical research across the nation. However, if we return to pre-ARRA funding levels in fiscal year 2011, we will have to curtail many promising research studies." As President, Talman will lead FASEB's advocacy efforts to encourage Congress and the Obama Administration to achieve the goal of sustainable funding for research.

A graduate of the University of Virginia School of Medicine, Talman's research focuses on the brain's control of the cardiovascular system, and his clinical specialty is autonomic dysfunction, for which he has been recognized by Best Doctors in America for the past eight years. Dr. Talman is the Past President of the International Society for Autonomic Neuroscience and past chair of the Public Affairs Committee of the American Physiological Society. He is also Associate Editor for Cellular and Molecular Neurobiology and has served as a reviewer for NIH Study Sections, VA Merit Review Boards, the National Science Foundation, and the American Heart Association.

Joseph C. LaManna, Ph.D., is FASEB's President-Elect and Fred D. Finkelman, M.D., the new Treasurer of the Federation. Dr. LaManna is a Professor of Physiology and Biophysics, Neurology and Neuroscience at the Case Western Reserve University School of Medicine and he has been involved as a cerebrovascular researcher for more than 30 years. Dr. Finkelman received his M.D. from Yale University and is a Professor of Medicine and Professor of Pediatrics at the University of Cincinnati College of Medicine.

FASEB is composed of 23 societies with more than 100,000 members, making it the largest coalition of biomedical research associations in the United States. FASEB enhances the ability of scientists and engineers to improve — through their research — the health, well-being, and productivity of all people. Our mission is to advance health and welfare by promoting progress and education in biological and biomedical sciences through service to our member societies and collaborative advocacy.


'/>"/>
SOURCE Federation of American Societies for Experimental Biology
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. FASEB Announces Recipient of the 2011 Excellence in Science Award
2. Cellectis to Present at the FASEB Summer Research Conference on Genome Engineering
3. FASEB Encourages NIGMS to Broaden Scientific Training Opportunities
4. Laureate Pharma Welcomes Three New Members to Business Development Team
5. Sundia Welcomes Professional U.S. Delegation
6. NovaMin Technology Inc. Welcomes New Board Member
7. BioStorage Technologies, Inc., Welcomes Catherine Michael as Global Head of Sample Management Operations
8. Trusted LASIK Surgeons Welcomes Fort Lauderdale Vision Correction Surgery Expert Raymond P. Gailitis, M.D., F.A.C.S.
9. UCLA welcomes startup to new incubator space at California NanoSystems Institute
10. Boston Scientific Welcomes Launch of Syntax Score Website
11. Trusted LASIK Surgeons Welcomes LASIK Expert William Mathers, M.D. of the Casey Vision Correction Center in Portland, Oregon, to Its LASIK Directory
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... States multicenter, prospective clinical study that demonstrates the accuracy of the FebriDx® ... identifying clinically significant acute bacterial and viral respiratory tract infections by testing ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... its endogenous context, enabling overexpression experiments and avoiding the use of exogenous expression ... guides is transformative for performing systematic gain-of-function studies. , This complement to ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. 11, ... Research, London (ICR) and University of ... SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma (MM), ... nine . The University of Leeds ... funded by Myeloma UK, and ICR will perform the testing ...
(Date:10/10/2017)... Los Angeles, CA (PRWEB) , ... ... ... Pharmaceuticals, Inc., a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) ... all uses of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed ...
Breaking Biology Technology:
(Date:3/28/2017)... PUNE, India , March 28, 2017 ... (Analog, IP, Biometrics), Hardware (Camera, Monitors, Servers, Storage Devices), ... Maintenance), Vertical, and Region - Global Forecast to 2022", ... 30.37 Billion in 2016 and is projected to reach ... 15.4% between 2017 and 2022. The base year considered ...
(Date:3/24/2017)... 2017 The Controller General of Immigration from Maldives ... Algeen have received the prestigious international IAIR Award for the most ... Reading ... Maldives ... Abdulla Algeen (small picture on the right) have received the IAIR award ...
(Date:3/23/2017)... March 23, 2017 The report "Gesture Recognition and Touchless ... and Geography - Global Forecast to 2022", published by MarketsandMarkets, the market is ... of 29.63% between 2017 and 2022. Continue Reading ... ... ...
Breaking Biology News(10 mins):